These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30389510)

  • 1. Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.
    Askaner K; Rydelius A; Engelholm S; Knutsson L; Lätt J; Abul-Kasim K; Sundgren PC
    J Neuroradiol; 2019 Nov; 46(6):367-372. PubMed ID: 30389510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
    She D; Xing Z; Cao D
    J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of brain abscesses from glioblastomas and metastatic brain tumors: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging before and after mathematic contrast leakage correction.
    Toh CH; Wei KC; Chang CN; Ng SH; Wong HF; Lin CP
    PLoS One; 2014; 9(10):e109172. PubMed ID: 25330386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRI.
    Jung BC; Arevalo-Perez J; Lyo JK; Holodny AI; Karimi S; Young RJ; Peck KK
    J Neuroimaging; 2016; 26(2):240-6. PubMed ID: 26235208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
    Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A
    PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
    Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
    Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging.
    Tupý R; Mírka H; Mraček J; Přibáň V; Hes O; Vokurka S; Ferda J
    Anticancer Res; 2018 Jul; 38(7):4149-4152. PubMed ID: 29970543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
    Sentürk S; Oğuz KK; Cila A
    Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
    Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
    Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
    Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
    Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI.
    Chawla S; Wang S; Mohan S; Nasrallah M; Verma G; Brem S; O'Rourke DM; Wolf RL; Poptani H; Nabavizadeh SA
    J Magn Reson Imaging; 2019 Jan; 49(1):184-194. PubMed ID: 29676844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.
    Wang S; Kim S; Chawla S; Wolf RL; Knipp DE; Vossough A; O'Rourke DM; Judy KD; Poptani H; Melhem ER
    AJNR Am J Neuroradiol; 2011 Mar; 32(3):507-14. PubMed ID: 21330399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
    Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
    AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion-weighted imaging of peritumoral edema can aid in the differential diagnosis of glioblastoma mulltiforme versus brain metastasis.
    Halshtok Neiman O; Sadetzki S; Chetrit A; Raskin S; Yaniv G; Hoffmann C
    Isr Med Assoc J; 2013 Feb; 15(2):103-5. PubMed ID: 23516772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions.
    Lin L; Xue Y; Duan Q; Sun B; Lin H; Huang X; Chen X
    Oncotarget; 2016 Oct; 7(42):69051-69059. PubMed ID: 27655705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.
    Kamimura K; Nakajo M; Yoneyama T; Fukukura Y; Hirano H; Goto Y; Sasaki M; Akamine Y; Keupp J; Yoshiura T
    Eur Radiol; 2019 Aug; 29(8):4133-4140. PubMed ID: 30488111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
    Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probabilistic independent component analysis of dynamic susceptibility contrast perfusion MRI in metastatic brain tumors.
    Chakhoyan A; Raymond C; Chen J; Goldman J; Yao J; Kaprealian TB; Pouratian N; Ellingson BM
    Cancer Imaging; 2019 Mar; 19(1):14. PubMed ID: 30885275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.